We have previously reported that the drs gene, whose mRNA expression is downregulated by retroviral oncogenes such as v-src and v-K-ras, has the ability to suppress transformation by v-src in a rat cell line F2408. We have now isolated a human homolog of this gene (hdrs) and found that the expression of h-drs mRNA is markedly downregulated in a variety of human cancer cell lines including those of the colon, bladder, and ovary. To investigate the function of the drs gene as a tumor suppressor in human cancer cells, we constructed recombinant amphotropic retrovirus containing the drs gene, introduced this virus into human cancer cell lines whose drs expression was downregulated and found that drs has the ability to suppress anchorage-independent growth of these cells without disturbing cell proliferation. Analyses with deletion mutants of the drs gene revealed that both the C-terminal region inside the transmembrane domain and three consensus repeats in the Nterminal region are essential for the suppression of anchorage-independent growth of the cells. We also found that the G1-S progression of the cell cycle and expression of cyclin A mRNA were signi®cantly suppressed in T24 cells expressing the drs gene under non-adhesion culture conditions. In contrast, the expression of cyclin D and E and the phosphorylation of Rb protein were not aected by ectopic expression of the drs gene, suggesting that an Rb-independent downregulation of cyclin A is involved in the suppression of anchorageindependent growth by means of the drs gene.
Introduction
Human oncogenesis involves multistep genetic alterations, including the activation of dominant oncogenes and the inactivation of tumor suppressor genes (Bishop, 1991; Vogelstein and Kinzler, 1993; Kinzler and Vogelstein, 1996) . The results of in vitro studies with viral transforming genes in rodent cells are also consistent with this notion. The introduction of a single oncogene into primary cell cultures is not sucient to induce malignant transformation, while the expression of multiple transforming genes is required to induce full transformation of primary cells (Land et al., 1983 (Land et al., , 1986 Ruley, 1983; Hirakawa and Ruley, 1988; MacAuley and Pawson, 1988; Schutte et al., 1989) . Experiments with somatic cell hybrids have shown that the genetic elements that can suppress malignant transformation are expressed in primary cells but not in established cell lines (Miyasaka et al., 1991; Inoue et al., 1995) . In searching for such transformation suppressor genes, we have isolated a novel gene, drs (downregulated by v-src) from a cDNA library of primary rat embryo ®broblast (Pan et al., 1996) . The drs gene is expressed in normal rat ®broblast cells but is completely downregulated in the cells transformed by the v-src gene (Pan et al., 1996; Inoue et al., 1998) . The drs gene has also been demonstrated to be downregulated by other retroviral oncogenes such as v-fps, v-ras, vmos, v-sis and v-abl but not by a large T antigen of simian virus 40 (SV40) and the E6/E7 genes of human papillomavirus. The drs cDNA has an open reading frame encoding 464 amino acid residues. This protein has one transmembrane domain, a short intracellular domain in the C terminus, and three consensus repeats conserved in the extracellular domain among the selectin family of adhesion molecules and complement-binding proteins (Bevilacqua et al., 1989; Johnston et al., 1989; Reid and Day, 1989; Siegelman et al., 1989; Norman et al., 1991; Lasky, 1992; Kansas, 1996) . We have demonstrated in a previous study that drs has the ability to suppress v-src and v-K-ras transformation without disturbing cell proliferation in a rat cell line F2408 (Inoue et al., 1998) . Recently, we have found that the drs gene is highly homologous to a human gene, SRPX/ETX1, which is deleted in patients with X-linked retinitis pigmentosa (Dry et al., 1995; Meindl et al., 1995) , indicating that this gene is a human homolog of the drs gene.
In this study, to clarify a possible function of the drs gene as a tumor suppressor in human oncogenesis, we examined the expression of the h-drs mRNA in human cancer cell lines by using a cloned human homolog of the drs gene (h-drs) and found that the expression of h-drs mRNA was downregulated in a variety of human cancer cell lines. In addition, we showed that the introduction of the drs gene into these cells suppressed the anchorage-independent growth of these cells, suggesting a tumor suppressor function. In a T24 bladder carcinoma cell line, we investigated in detail the mechanism for the suppression of anchorage-independent growth by the drs gene.
Results

Expression of h-drs mRNA in human normal tissues and cancer cell lines
To investigate the role of the drs gene as a tumor suppressor in human carcinogenesis, we isolated the cDNA of a human homolog of the drs gene from a cDNA library of human embryo ®broblasts as described in Material and methods. The h-drs gene had 87.5% homology at the nucleotide level and 93.1% identity at the amino acid level (Figure 1a) to the rat drs gene in the coding region. Initially, we examined the expression of h-drs mRNA in normal human tissues by Northern hybridization using the isolated hdrs cDNA as a probe. As shown in Figure 1b , the expression of h-drs mRNA was detected in most of the tissues examined except for the peripheral blood leukocytes and the spleen. In particular, the h-drs mRNA was highly expressed in tissues such as the heart, colon, small intestine, ovary, testis, and prostate. By using the h-drs probe, we also investigated the expression of h-drs mRNA in a variety of human cancer cell lines. In cell lines such as MIA-PaCa-2 (pancreatic carcinoma cell line), AZ521 (gastric ca.), T24 (bladder ca.), SW837 (rectum ca.), G401 (Wilm's tumor), S3 (epitheloid ca.), C33A, CaSki, and HeLa (cervical ca.), the expression of h-drs mRNA was markedly decreased compared with that of human embryo ®broblasts (HEF), while the expression of hdrs mRNA was similar to that of HEF in the cell lines RERF-LC-MS (lung ca.), MeWo (melanoma), NB-1 (neuroblastoma), A172 (glioblastoma), and HT1080 (®brosarcoma). As the h-drs mRNA was highly expressed in the normal colon, ovary, and testis, as shown in Figure 1b, we further examined the level of hdrs mRNA in six colon carcinoma cell lines ( Figure  2b ), three testicular cancer, and ®ve ovarian cancer cell lines (Figure 2c ). For the colon cancer cell lines, we used normal human colon cells (FHC) as a positive control. The h-drs mRNA was signi®cantly expressed in the FHC cells, although the level of h-drs mRNA was lower than that of HEF because of the smaller amount of mRNA loaded (lower panel of Figure 2b , see actin mRNA). Expression of h-drs mRNA was markedly decreased in all of the colon carcinoma and testicular cancer cell lines examined and two of the ®ve ovarian cancer cell lines. Southern hybridization experiments were able to detect no large deletions or rearrangements in the genome of the h-drs gene in cell lines whose levels of h-drs mRNA were markedly reduced (Figure 2d ± f) . These results suggest that expression of the h-drs gene is downregulated in some kinds of human cancer cell lines such as those of the colon, testis and ovary as well as rat ®broblast cell lines transformed by viral oncogenes, indicating that the drs gene may play a role as a tumor suppressor.
Suppression of anchorage-independent growth by the drs gene in human cancer cell lines
To clarify whether the drs gene suppresses the transformed phenotype of human cancer cell lines, we constructed a recombinant amphotropic retrovirus containing the drs gene (pBabePuro/drs); this virus and the vector virus (pBabePuro) were then introduced into colon (LoVo, WiDr, and DLD-1), bladder (T24) and ovarian (MCAS) carcinoma cell lines in which the expression of h-drs mRNA was markedly downregulated. Puromycin-resistant colonies were pooled and the colony forming abilities of these cells in soft agar were examined. As shown in Figure 3a , the colony-forming eciencies of the cells expressing exogenous drs in soft agar were signi®cantly lower than those of the cells containing vector virus, although the degree of suppression was dierent in each cell line. However, ectopic expression of the exogenous drs gene did not aect cell proliferation (Figure 4) . Northern hybridization experiments demonstrated that these cell lines expressed exogenous drs mRNA in signi®cant quantities although WiDr expressed smaller amount of drs mRNA than other cell lines (Figure 3b ). High expression of drs mRNA may be lethal for WiDr. We also examined the eect of drs on the tumorigenicity in WiDr and found that tumor growth of WiDr-drs was slower than that of WiDr-BP (data not shown), suggesting that the inhibition of anchorage-independent growth by drs correspond to the reduction of the tumorigenicity at least in WiDr. To further con®rm the correlation between the expression of drs mRNA and the suppression of anchorage-independent growth, we cultured and examined the expression of drs mRNA in several of the large colonies produced by T24 expressing the drs gene in soft agar. As shown in Figure 3c and d, all of these clones (SA-1, 2, 3 and 4) lost the ability to both express drs mRNA and suppress anchorage-independent growth. On the other hand, when we randomly picked up ten clones from the liquid culture of T24 cells expressing the drs gene, all clones retained both drs mRNA expression and the suppression activity (data not shown). From these results, we can conclude that the drs gene has the ability to suppress anchorage-independent growth of these human cancer cell lines without disturbing cell proliferation.
Deletion mutant analyses of the suppression activity of drs To identify the domains of drs responsible for the suppression of anchorage-independent growth, we constructed three deletion mutants of this gene, that lacked either the C-terminal region 19 amino acids EcoRI-digested genomic DNA (20 mg), which was prepared from human cancer cell lines whose mRNA expression was reduced in (a ± c), was hybridized with a h-drs cDNA probe (CD), the C-terminal region and a part of the transmembrane domain (TM), or the N-terminal region containing three consensus repeats (ND) (Figures 1a and 5a ). We then produced recombinant amphotropic viruses containing these mutants of drs as well as wild type (WT) drs and introduced these viruses into a T24 bladder carcinoma cell line in which suppression of anchorage-independent growth by drs was most evident, as evident in Figure 3a . After puromycin selection, the anchorage-independent growth of the virus-infected T24 cells was investigated. As shown in Figures 5b and 6 , all of three deletion mutants failed to suppress colony-formation of T24 in soft agar, in the ND mutant, however, there were 2.5-fold more colonies, and the colonies were smaller. The growth rates of these cells were similar ( Figure 5c ). The expression of viral mRNAs of WT drs and the deletion mutants in T24 was con®rmed by Northern hybridization (Figure 5d ). To make sure that the expression of WT and mutant drs proteins was from these constructs, we inserted Flag-tag into WT and mutant drs genes and transfected these Flag-tagged constructs (WT-, CD-, TM-and ND-Flag) into Cos1 cells. Immunoblotting with anti-Flag antibody indicated that the size of the drs proteins corresponded to that of WT and each of the mutant drs, con®rming that these proteins were expressed from these constructs ( Figure 5e ). These results indicate that both the N-terminal regions containing three consensus repeats and the C-terminal 19 amino acids region are necessary for the drs gene to suppress anchorage-independent growth in T24 cells.
Eect of drs on cell cycle progression
To clarify the mechanism by which the drs gene suppresses anchorage-independent growth, we initially examined the eect of drs on cell cycle progression under adhesion or non-adhesion (suspension) culture conditions in T24 cells. Con¯uent cultures of T24-BP and T24-drs cells were serum-starved for 24 h, trypsinized, stimulated by serum (10% FCS), and cultured under adhesion or suspension conditions. After an 18 h incubation, the cell cycle status of these cells was analysed by¯ow cytometry-activating cell sorting (FACS). Figure 7 shows the results. Sixty to seventy per cent of the T24-BP and the T24-drs cells were in S phase under adhesion conditions. On the other hand, under suspension conditions, entry into S phase of T24-drs cells was signi®cantly suppressed compared to that of the T24-BP cells. Viral drs mRNA was equally expressed irrespective of adhesion in the T24-drs cells (Figure 8a ). These results indicate that the drs gene suppresses G1/S progression of the cell cycle under non-adhesion conditions.
Eect of drs on activation of Erk2 kinase and expression of immediate early genes
The T24 bladder carcinoma cell line is known to have an activating mutation of the endogenous H-ras gene that seems to be responsible for the malignant phenotype of this cell line (Pulciani et al., 1982; Shih and Weinberg, 1982; Taparowsky et al., 1982) . To test whether the expression of drs suppresses the down- stream pathways of activated H-ras, we investigated the activation of Erk2 kinase and the expression of cfos, c-jun and c-myc mRNA in both T24-BP and T24-drs cells under adhesion or suspension culture conditions. Activation of Erk2 kinase, a serine/ threonine kinase, which is activated downstream of Ras via Raf-1 (Howe et al., 1992 ; Davis, 1993; Cobb and Goldsmith, 1995) , was examined by immunoblotting with the anti-Erk2 monoclonal antibody. As shown in Figure 8b , the amounts of the phosphorylated (active) form of Erk2 (upper band) were similar in all lanes, indicating that drs does not suppress the activation of Erk2 kinase by activated H-ras in T24. The expression of c-jun and c-myc mRNA was also not aected by the drs gene under either adhesion or suspension conditions. The expression of c-fos mRNA was not detected in T24 cells under these experimental conditions (data not shown). These results suggest that the action point of drs in the suppression of G1/S progression in non-adhesion conditions is further downstream of activation of Erk2 kinase and expression of c-jun and c-myc mRNA.
Downregulation of cyclin A in suspension culture of T24-drs
In mammalian cells, the cell cycle-dependent expression of cyclin D, E and A is considered to be critical for the G1/S progression of the cell cycle Pines, 1991, 1994; Sherr, 1993) . These cyclins associate and activate their counterpart kinases (cdk4/6 for cyclin D, cdk2 for cyclin E and cyclin A). The cyclin D-cdk4/6 and cyclin E-cdk2 complexes phosphorylate the retinoblastoma susceptibility protein (pRb) and release the E2F transcription factor, which activates the cellular genes such as cyclin A that are required for S phase entry (Nevins, 1992; Weinberg, 1995) . To clarify which molecules are involved in the suppression of anchorage-independent growth by the drs gene, we investigated the expression of the proteins regulating G1/S progression by immunoblotting the speci®c antibodies in T24-BP and T24-drs cells under adhesion or suspension conditions. As shown in Figure 9a , cyclin D, E, cdk2, cdk4 and cdk inhibitors, p21 and p27, were similarly expressed in T24-BP and T24-drs cells under both adhesion and suppression conditions. As a result, phosphorylation of the Rb proteins was not aected by the expression of drs under both adhesion and suspension conditions. On the other hand, the expression of cyclin A protein was most signi®cantly reduced only in the suspension culture of T24-drs. To examine whether the reduced expression of cyclin A protein in T24-drs was due to downregulation of cyclin A mRNA, we performed Northern hybridiza- Percentages of the cells in G1, S and G2/M phases tion using human cyclin A cDNA as a probe. As shown in Figure 9b , the expression of cyclin A mRNA was also completely downregulated in suspension culture of T24-drs, indicating that the downregulation of cyclin A protein is due to the reduced expression of cyclin A mRNA. The expression of cyclin A mRNA was recovered in parallel with the G1/S progression of the cell cycle by re-adhesion of the suspension culture of T24-drs cells (Figure 9c and d) , indicating that G1 arrest of T24-drs in suspension conditions is not caused by cellular damage such as apoptosis and that the expression of cyclin A mRNA closely correlates with the entry of T24-drs cells into S phase. These results suggest that, in the T24 cell, the drs gene prevents G1/S progression of the cell cycle under non-adhesion conditions and suppresses anchorage-independent growth through the downregulation of cyclin A at the transcriptional level.
Discussion
In this study, we initially showed that the expression of h-drs mRNA is downregulated in various kinds of human carcinoma cell lines, including those of colon, bladder, testis, and ovary. We could not ®nd any gross deletion or rearrangement in the genome of the h-drs gene by Southern hybridization in these cancer cell lines whose levels of drs mRNA were markedly reduced. This phenomenon is similar to our previous ®nding that the expression of drs mRNA is down- Suppression of anchorage-independent growth by drs gene A Yamashita et al regulated in rat ®broblast cell lines transformed by viral oncogenes such as v-src and v-K-ras (Pan et al., 1996; Inoue et al., 1998) . By using a temperaturesensitive mutant of v-src, we have demonstrated that the downregulation of drs mRNA is dependent on the expression of v-Src tyrosine kinase (Inoue et al., 1998) . The simplest explanation for the reduced expression of h-drs mRNA in human cancer cell lines is that expression of h-drs mRNA is downregulated by the activation of endogenous oncogenes. In fact, the activation of endogenous proto-oncogenes such as ras and src has been reported for colon, pancreatic, gastric, and bladder carcinoma cell lines including LoVo, DLD-1, WiDr, and T24 (Pulciani et al., 1982; Shih and Weinberg, 1982; Taparowsky et al., 1982; Der and Cooper, 1983; Bolen et al., 1987; Bos, 1989; Cartwright et al., 1989; Shirasawa et al., 1993; Nagase et al., 1997) . Another possible mechanism for the downregulation of the h-drs gene involves regulation by the APC-bcatenin pathway. In our experiments, the h-drs mRNA was clearly downregulated in all colon carcinoma cell lines examined. In colon cancer, inactivation of an APC tumor suppressor gene has been reported to cause activation of Tcf-4/Lef-1 transcription mediated by bcatenin (Kinzler and Vogelstein, 1996; Korinek et al., 1997; Morin et al., 1997; Rubinfeld et al., 1997) . Recently, c-myc has been shown to be upregulated by the APC-b-catenin pathway (He et al., 1998) . It may be possible that expression of the h-drs gene is negatively regulated by Tcf-4/Lef-1 downstream of the APC-bcatenin pathway. In colorectal tumorigenesis, inactivation of the APC gene is considered to be an initiation step, while activation of the ras gene is involved in the process of tumor progression (Vogelstein and Kinzler, 1993; Kinzler and Vogelstein, 1996) . It is important to determine which genetic alteration is closely correlated with the downregulation of the drs gene in colon carcinogenesis. Inactivation of the h-drs gene by DNA methylation is also plausible for downregulation of hdrs mRNA because the expression of many genes is suppressed by this mechanism in cancer cells (Counts and Goodman, 1995; Jones and Gonzalgo, 1997) . However, we cannot at present completely exclude the possibility that minor mutations of the genomic drs are responsible for the downregulation of h-drs mRNA in these cell lines. Detailed analyses of the genome of the h-drs gene in these cancer cell lines is also necessary.
We have also demonstrated that the ectopic expression of the drs gene suppresses anchorageindependent growth of these cancer cell lines without aecting cell proliferation. This ®nding, together with the observed downregulation of the h-drs gene in human cancer cell lines, suggests a close relationship between the downregulation of drs and the expression of a malignant phenotype in human cancer cell lines, supposing a tumor suppressor function for drs. In addition, by carrying out analyses with deletion mutants of drs we found that both cytoplasmic domain and extracellular consensus repeats (CR) are necessary to suppress the anchorage-independent growth of T24 cells. These ®ndings suggest that the drs protein functions as a kind of receptor that accepts extracellular signals in the consensus repeat region, transduces the signals into the nucleus via a small intracellular domain, and regulates the cell cycle progression. Three complement-binding protein motifs (CR) are conserved in the selectin family (Jutila et al., 1992; Lasky, 1992) , and although the role of CR in selectin is not yet well de®ned, it has been suggested that CR are involved in the adhesion function of both L-and E-selectins (Jutila et al., 1992; Li et al., 1994) . In addition to adhesion function, E-selectin has been shown to associate with actin-associated proteins such as a-actinin, vinculin, ®lamin, paxillin and focal adhesion kinase (FAK) (Yoshida et al., 1996) . Lselectin has also been reported to act as a signaling molecule that activates MAP kinase and Ras pathways through tyrosine phosphorylation (Waddell et al., 1995; Brenner et al., 1996) . The drs protein might also act similarly as a signaling molecule, although drs has no homology with the selectin family except for the CR motifs. In Figure 5b , it can be seen that the expression of the CR deletion mutant (ND) induced 2.5-fold more colonies in soft agar than the C-terminal deletion mutant (CD) and vector only (BP) although the size of colonies was small. These results suggest that the lack of CR results not only in a loss of suppressor function but also the stimulation of oncogenic function probably because of abnormal signaling by constitutive expression of C-terminal domain alone. The reduction in size of colonies by ND mutant may be due to partial suppressor activity by the remaining extracellular region. To fully understand the function of drs, it would be necessary to analyse the role played by the N-terminal region containing CR motifs.
Thirdly, we investigated the mechanism by which anchorage-independent growth is suppressed by the drs gene in T24 cells under adhesion or suspension conditions, and found that G1-S progression of the cell cycle and the expression of cyclin A mRNA were suppressed in T24 cells expressing the drs gene under non-adhesion conditions. Guandagno et al. (1993) have shown that the expression of cyclin A is critical for anchorage-dependent progression of the cell cycle in normal rodent ®broblast cell lines, NIH3T3 and NRK, and that ectopic expression of cyclin A induces anchorage-independent growth in NRK. These findings are consistent with our result, indicating that the downregulation of cyclin A mRNA is closely correlated with the suppression of anchorage-independent growth of T24 cells by drs. It has also been reported that the expression of cyclin D1 and the activation of cyclin E/ cdk2 are dependent on cell adhesion (Fang et al., 1996; Zhu et al., 1996; Assoian, 1997) . Phosphorylation of the Rb protein has also been shown to be anchoragedependent in NIH3T3 and human ®broblast cells (Zhu et al., 1996) . However, Zhu et al. (1996) have also reported that, in NRK cells, cyclin A expression is not induced in suspension culture, irrespective of hyperphosphorylation of the Rb protein, suggesting an Rbindependent pathway of expression of cyclin A. In our case, neither the expression of cyclin D or E nor the phosphorylation of Rb protein were aected by the ectopic expression of drs in T24 cells under either adhesion or suspension conditions (Figure 9a ), indicating that transcriptional downregulation of cyclin A by drs in suspension culture is caused by an Rb-independent pathway. In fact, the transcription of cyclin A mRNA has been shown to be positively or negatively regulated by multiple factors including E2F, CREB, CREM, and CDE (Desdouets et al., 1995; Lucibello et al., 1995; Nakamura et al., 1995; Schulze et al., 1995) . It seems possible that drs downregulates the transcription of cyclin A by aecting E2F-independent pathways.
In T24 cells, G1/S progression and the expression of cyclin A were suppressed by drs only in the suspension culture. This implies that an integrin-mediated signaling pathway may be involved in the drs signaling pathway regulating the expression of cyclin A. Integrins regulate cell growth, cell survival, and cell dierentiation through interaction with the extracellular matrix (ECM) (Hynes, 1992; Clark and Brugge, 1995; Giancotti, 1997; Schwartz, 1997; Kumar, 1998) . Intracellular regions of integrins associate with components of the focal adhesion complex such as paxillin and FAK and an adoptor molecule, shc, which regulates adhesiondependent cell cycle progression via a Ras-MAP kinase pathway (Schlaepfer et al., 1994; Wary et al., 1996; Schwartz, 1997; Kumar, 1998) . Further experiments are necessary to work out how integrin-and drs-signaling pathways interact to regulate anchorage-independent growth. The elucidation of drs function will provide new insights into the molecular mechanism of the anchorageindependent growth of cancer cells.
Materials and methods
Cells
The human cells used in this study were HEF (human embryo ®broblast), FHC (normal human colon cell), RERF-LC-MS (lung carcinoma cell line), MIA-PaCa-2 (pancreatic ca.), MeWo (melanoma), AZ521 (gastric ca.), NB-1 (neuroblastoma), A172 (glioblastoma), HT1080 (fibrosarcoma), T24 (bladder ca.), SW837 (rectum ca.), G401 (Wilm's tumor), S3 (epitheloid ca.), C33A, SiHa, CaSki, HeLa (cervical ca.), DLD-1, SW837, COLO201, LoVo, CKK-81, COLO320 (colon ca.), NEC-8, ITO-II, Tera2 (testicular ca.), PA-1, MCAS, Ca-OV3, SK-OV3 and TKY-nu (ovarian ca.). Cos1 is an African green monkey kidney cell line (CV-1) transformed by a replication origin mutant of simian virus 40 (Gluzman, 1981) . Cells were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS) (growth medium). COLO320DM (JCRB0225), DLD-1 (JCRB9094), LoVo (JCRB9083), WiDr (JCRB0224), COLO201 (JCRB0226), NEC-8 (JCRB0250), MCAS (JCRB0240) and PA-1 (JCRB9061) cancer cell lines were obtained from the Health Science Research Resources Bank. FHC (CRL1831) was obtained from ATCC. TKY-nu, SK-OV3, and Ca-OV3 were kindly provided by Dr Satoru Kyo (Kanazawa University).
Construction of recombinant plasmids and drs mutants
A human homolog of drs (h-drs) was ampli®ed by PCR with a pair of oligoprimers (5'-TCGTCGCCGAGGCGAGCTAA and 5'-CCAAGAGAGGAACCATCATG) for the 5' and 3' sequences of SRPX (Dry et al., 1995; Meindl et al., 1995) , cloned to the pCR2.1 vector (Invitrogen), and sequenced. The drs mutants lacking a 57-bp C-terminal region (CD) and a 177-bp C-terminal region containing a part of transmembrane domain (TM) were ampli®ed by PCR with an oligoprimer (5'-ATCTTGGCCTCCTCCAGCCC) for 5'-UTR of drs and a 3' primer (TM; 5'-TCACAACCT-GAGCTGCAGAG, CD; 5'-TCAGAAAGTGTCAAT-GAGGT) containing a stop codon for a respective targeted sequence. These PCR products cloned to the pCR2.1 vector were sequenced. The mutant lacking a 792-bp N-terminal region of three consensus repeats (ND) was constructed by AluI and PvuII digestion and ligation. All series of the drs gene, including the full-length wild type (WT) and the three mutants (CD, TM and ND), were cloned in pBabepuro retrovirus vector containing murine retrovirus LTR promoter (Morganstern and Land, 1990) . The recombinant plasmids were prepared using Qiagen column (Qiagen).
Construction of Flag-tagged drs
The synthesized Flag-tag was inserted into the BsmI site of the drs gene (WT) and three deletion mutants (CD, TM and ND).
Construction of recombinant retrovirus
The pBabepuro retrovirus vectors carrying the drs wild type and mutants were transfected into c2 cell (a packaging cell line for ecotropic murine retrovirus) (Mann et al., 1983) and the transfectants were selected in medium containing puromycin (2 mg/ml). Genomic DNA of each of the clones was isolated, and integration of the exogenous drs gene was checked by Southern hybridization. The culture medium was collected from the c2 clones containing the exogenous drs gene. To produce an amphotropic virus, the culture medium containing the ecotropic virus was introduced into the PA317 cell (Miller and Buttimore, 1986 ) and the infected cells were selected in puromycin medium. The amphotropic virus in the culture medium was collected, and the titer of virus was assayed through its introduction into NIH3T3 and then selection by puromycin.
Virus infection
2610
5 cells were plated on a 60-mm dish and cultured overnight at 378C. After polybrane treatment (2 mg/ml) for 30 min, the amphotropic virus was added to the cultures and incubated for 1 h at 378C. After 10 days incubation in selection medium (puromycin 2 mg/ml), the puromycinresistant colonies were pooled and used for the transformation assay.
DNA transfection
The calcium phosphate method (Wigler et al., 1978) was used for c2, and the lipofectamine method (GIBCO ± BRL) was used for transient transfection into Cos1.
Soft agar assay
To assess the colony formation in soft agar, 1610 4 cells were inoculated into 0.5% agar containing DMEM supplemented with 10% FCS in a 60-mm dish. After 2 weeks of incubation, the number of large colonies (over 0.125 mm in diameter) in each plate was scored. Each cell line was tested in duplicate dishes in two or three independent assays.
Cell cycle analysis
Cell cycle analysis was carried out by measuring the cellular DNA content by¯ow cytometry-activated cell sorting (FACS). To isolate and stain the cell nuclei, the Cycle TEST TM plus DNA Reagent Kit (Becton Dickinson) was used. Cells were washed with phosphate-buered saline [PBS(7)], suspended in sodium citrate buer, quickly frozen in a bath of dry ice-methanol, and stored at 7808C until use. The cells were thawed, and their DNA was stained by Cycle TEST Reagent using the procedures recommended by the manufacturer. The¯uorescence of the cells was measured by a FACScan system (Becton Dickinson), and the percentages of cells in G1, S, and G2/M phase were determined by the ModFit program (Becton Dickinson).
Northern blot analysis
Total RNA was isolated from cells by the guanidium isothiocyanate-cesium chloride method (Chirgwin et al., 1979) . Samples of 20 mg of total RNA from cells were subjected to electrophoresis on a 1% agarose gel containing a 1.8% formaldehyde and then transferred to a nylon ®lter. The ®lter was then hybridized with 32 P-labeled probes at 418C overnight in hybridizing buer (50% formamide, 0.6 M sodium chloride, 60 mM sodium citrate, 0.2% sodium dodecyl sulfate (SDS), 0.1% bovine serum albumin (BSA), 0.1% Ficoll, 0.1% polyvinylpyrrolidone and 50 mg of herring sperm DNA/ml). The hybridized ®lters were washed with 15 mM sodium chloride, 1.5 mM sodium citrate and 0.1% SDS at 508C and then autoradiographed.
Southern blot analysis
Isolation of cellular high-molecular-weight DNA and blot hybridization were performed as described previously (Southern, 1975; Blin and Staord, 1976) . DNA from each sample was digested with restriction enzymes, separated by 1% agarose gel electrophoresis, and transferred to a nylon ®lter. Hybridization and washing were performed as described for the Northern blot analysis.
Antibodies
Anti-Cyclin A (cat.#06-138, polyclonal), anti-Cyclin E (#06-134, polyclonal) and anti-Erk2 (#05-157, monoclonal) antibodies were purchased from Upstate Biotechnology. Anti-Cyclin D1 (HD11, monoclonal), anti-cdk2 (C-22, polyclonal), anti-cdk4 (M2, polyclonal), and anti-Rb (C-15, polyclonal) antibodies were purchased from Santa Cruz Biotechnology. Anti-p21 (#15441A, monoclonal) and antip27 (#13231, monoclonal) antibodies were purchased from PharMingen. Anti-Flag antibody (monoclonal) was purchased from Sigma.
Immunoblotting
The cells were lysed in Laemmli ± SDS buer containing 62.5 mM Tris-HCl (pH 6.8), 10% glycerol, 5% 2-mercaptoethanol, 2% SDS, 0.01% bromophenol blue, 5 mM EDTA and 1 mM orthovanadate. Lysates were boiled for 5 min, sonicated, and stored at 7808C until use. The samples of cell lysate, which contained equal amounts of protein, were subjected to SDS-polyacrylamide gel electrophoresis (SDS ± PAGE), and the separated proteins were electro-transferred to membrane ®lters (Immobilon-P, Millipore). After blocking with TBS-T (10 mM Tris-HC1, pH 7.6, 150 mM sodium chloride, 0.1% Tween 20) containing 5% BSA, the ®lters were incubated with an antibody described above in TBS-T containing 2% BSA for up to 5 h. The ®lters were then washed in TBS-T and incubated for 1 h in horseradish peroxidase-conjugated mouse or rabbit IgG (Amersham International plc.) diluted 1 : 20 000 in TBS-T containing 2% BSA. After several washes in TBS-T, the immunoreactivity was detected by the ECL system (Amersham International plc.) using procedures recommended by the manufacturer.
